SCHEMBL14224356

SCHEMBL14224356

c1ccc(-c2cccc(-c3ncc(-c4ccnc(Nc5cccc(OCCCN6CCNCC6)c5)n4)[nH]3)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AIMP2 Q13155 1/20 0.48
EGFR P00533 2/20 0.46
ABL1 P00519 2/20 0.46
BCR P11274 2/20 0.46
SRC P12931 2/20 0.46
PRKCA P17252 1/20 0.46
PRKCD Q05655 1/20 0.46
SYK P43405 4/20 0.44
CAMK2D Q13557 1/20 0.42
ACVR1 Q04771 1/20 0.41
JAK2 O60674 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
GSK3B P49841 3/20 0.41
CDK2 P24941 2/20 0.40
INSR P06213 1/20 0.40
IGF1R P08069 1/20 0.40
MET P08581 1/20 0.40
KDR P35968 1/20 0.40
TEK Q02763 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14224454 0.94 AIMP2 (0.47) AIMP2EGFRABL1BCRSRC
SCHEMBL14224358 0.94 AIMP2 (0.49) AIMP2EGFRABL1BCRSRC
SCHEMBL14224091 0.93 SYK (0.49) AIMP2EGFRABL1BCRSRC
SCHEMBL14224274 0.92 AIMP2 (0.51) AIMP2EGFRABL1BCRSRC
SCHEMBL14224133 0.92 ABL1 (0.50) AIMP2EGFRABL1BCRSRC
SCHEMBL14224451 0.92 AIMP2 (0.47) AIMP2EGFRABL1BCRSRC
SCHEMBL14224086 0.92 AIMP2 (0.49) AIMP2EGFRABL1BCRSRC
SCHEMBL14224126 0.92 AIMP2 (0.47) AIMP2EGFRABL1BCRSRC
SCHEMBL14195975 0.92 AIMP2 (0.49) AIMP2EGFRABL1BCRSRC
SCHEMBL14196025 0.91 ABL1 (0.54) AIMP2EGFRABL1BCRSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7361665-B2 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-04-22 US disclosed